Addus HomeCare Corporation (ADUS) Earnings: Q3 2026 Results

The quarter ended September 30, 2026 and Addus HomeCare published the results on November 3, 2026. Revenue and diluted EPS are shown against Q3 2025, the same quarter a year earlier, which takes seasonal swings out of the comparison. Addus HomeCare reports EPS two ways: GAAP, under the accounting rules every US filer follows, and adjusted net income per diluted share, which leaves out items the company considers outside its operating results. The release reconciles the two, and when they diverge, the reconciliation says why.

• Revenue here is Addus HomeCare's net service revenues. Its hospice comparison is affected by an implicit price concession benefit in Q3 2025; Addus says hospice organic revenue rose 8.8% excluding it.

Source: Addus HomeCare Q3 2026 results, November 3, 2026. Also in the Form 10-Q for the quarter ended September 30, 2026. Figures as reported; checked against the release on November 10, 2026.

How Addus HomeCare splits revenue in its own release, under its own labels, for Q3 2026 against Q3 2025. Indented lines are parts of the line above them.

• Addus HomeCare's Personal Care revenue was $301 million in Q3 2026, up 9% from $276 million in Q3 2025, 78% of total revenue.
• Addus HomeCare's Hospice revenue was $69.0 million in Q3 2026, flat on $68.9 million in Q3 2025, 18% of total revenue.
• Addus HomeCare's Home Health revenue was $17.7 million in Q3 2026, flat on $17.6 million in Q3 2025, 5% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

GAAP net service revenues and net income per diluted share, each as first reported in that quarter's release.

We do not hold a confirmed date for Addus HomeCare's next report. Companies post the date on their investor relations site a few weeks ahead, usually with the time of the conference call.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q3 2026 (this page), reported Nov 3, 2026

Addus HomeCare's net service revenues rose 7.0% to $387.7 million in Q3 2026 from $362.3 million. Personal care, help with activities of daily living for people at risk of hospitalization or institutionalization, was $301.0 million, or 77.6% of revenue. Hospice was $69.0 million (17.8%) and home health $17.7 million (4.6%). (Addus HomeCare Q3 2026 release, Nov 3, 2026)

Personal care revenue grew 6.9% organically. Addus credited organic volume, the first full quarter from its HomeCourt Home Care acquisition in Indiana, completed May 1, 2026 for $12.2 million, and earlier rate increases in states including Illinois, Texas and New Mexico. Revenues per billable hour rose to $26.67 from $25.40 and billable hours to 11.3 million from 10.9 million. (Addus HomeCare Q3 2026 release, Nov 3, 2026; Addus HomeCare Form 10-Q, Q3 2026, Nov 4, 2026)

Hospice average daily census rose 4.3% organically to 4,037, and hospice revenue was nearly flat because Q3 2025 included an implicit price concession benefit; excluding it, Addus says hospice organic revenue rose 8.8%. Home health returned to organic revenue growth of 2.5%, with new admissions up 13.8%. (Addus HomeCare Q3 2026 release, Nov 3, 2026)

Addus is concentrated in Illinois and in government payors. Illinois produced 31.2% of net service revenues in the quarter, and the Illinois Department on Aging alone 17.4%. Managed care organizations accounted for 38.3% of net service revenues, and hospice revenue was 94.3% Medicare. (Addus HomeCare Form 10-Q, Q3 2026, Nov 4, 2026; Addus HomeCare Q3 2026 release, Nov 3, 2026)

Addus HomeCare's net income rose to $28.6 million, or $1.54 per diluted share, from $22.8 million, or $1.24. Adjusted net income per diluted share rose 17.3% to $1.83 from $1.56. The adjusted figure excludes acquisition expenses ($0.16 per share), stock-based compensation ($0.12) and restructure and other non-recurring costs ($0.01). (Addus HomeCare Q3 2026 release, Nov 3, 2026)

Lower interest helped. Net interest expense fell to $0.7 million from $2.6 million as long-term debt dropped to $21.9 million from $150.6 million a year earlier, leaving bank debt of $24.3 million at September 30, 2026. Income tax expense was $10.5 million on pre-tax income of $39.1 million. (Addus HomeCare Q3 2026 release, Nov 3, 2026)

The share count barely moved: diluted weighted average shares were 18.6 million against 18.4 million. Gross margin was 32.1% against 32.2%, and general and administrative expenses rose to $80.4 million from $79.4 million. (Addus HomeCare Q3 2026 release, Nov 3, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

Addus HomeCare's Q3 2026 release gives no revenue or earnings outlook. It points instead to the pending acquisition of AccentCare's personal care division outside New York for about $275.0 million, which Addus says adds roughly $280 million of annualized revenue and is expected to close after regulatory approvals. (Addus HomeCare Q3 2026 release, Nov 3, 2026)

A consensus figure is the average of the models published by the analysts who cover Addus HomeCare, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones Addus HomeCare's own release and filings put weight on for Q3 2026, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning ADUS is on is ADUS a buy or a sell?, what analysts expect next is on the ADUS forecast, and what the company does is on the Addus HomeCare Corporation (ADUS) stock page.

Every number on this page can be traced to a document Addus HomeCare published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.